Cargando…

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case

BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibri...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Yasuhisa, Suenari, Kazuyoshi, Yamashiro, Kohei, Nakagawa, Hiroshi, Shiode, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071569/
https://www.ncbi.nlm.nih.gov/pubmed/32169057
http://dx.doi.org/10.1186/s12872-020-01405-4
_version_ 1783506231449616384
author Nakao, Yasuhisa
Suenari, Kazuyoshi
Yamashiro, Kohei
Nakagawa, Hiroshi
Shiode, Nobuo
author_facet Nakao, Yasuhisa
Suenari, Kazuyoshi
Yamashiro, Kohei
Nakagawa, Hiroshi
Shiode, Nobuo
author_sort Nakao, Yasuhisa
collection PubMed
description BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibrillation (VF) storms. CASE PRESENTATION: A 24-year-old man underwent a bout of syncope with vomiting and incontinence at home. He was brought to the emergency room and was witnessed to spontaneously go into VF successfully converted by external defibrillation. Previously, he was diagnosed with a type I Brugada electrocardiogram pattern by a pilsicainide administration test in another hospital. Although he had a family history of sudden cardiac death in 3 relatives, including his brother, he was followed closely without any therapies because he had never had an episode of syncope. He was implanted with an S-ICD without any trouble. Seven months later, frequent S-ICD shocks for VF storms occurred. His VF was controlled by using intravenous amiodarone, which was converted to an oral preparation. However, his VF recurred after another 2 months. The analysis of his S-ICD data revealed that 4 consecutive shock deliveries could not terminate his VF and the final shock delivered could fortunately terminate it because of a high defibrillation threshold test (DFT) due to an increasing shock impedance (64 to 90 Ω). First, we performed an epicardial Brugada syndrome ablation and subsequently replaced and repositioned the S-ICD lead from a left to a right parasternal site. After the re-implantation of the S-ICD, the DFT test improved to within normal range. According to the pathological analysis, infiltration of inflammatory cells and extensive fibrosis were confirmed in the subcutaneous tissue around the shock lead and S-ICD body. CONCLUSION: Frequent S-ICD shocks for VF storms might cause various pathological changes around the device and lead to a high DFT.
format Online
Article
Text
id pubmed-7071569
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70715692020-03-18 Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case Nakao, Yasuhisa Suenari, Kazuyoshi Yamashiro, Kohei Nakagawa, Hiroshi Shiode, Nobuo BMC Cardiovasc Disord Case Report BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S-ICD) is an alternative to the transvenous implantable cardioverter defibrillator for the prevention of sudden cardiac death. Here, we report a rare case of refractoriness to an S-ICD after frequent therapies for ventricular fibrillation (VF) storms. CASE PRESENTATION: A 24-year-old man underwent a bout of syncope with vomiting and incontinence at home. He was brought to the emergency room and was witnessed to spontaneously go into VF successfully converted by external defibrillation. Previously, he was diagnosed with a type I Brugada electrocardiogram pattern by a pilsicainide administration test in another hospital. Although he had a family history of sudden cardiac death in 3 relatives, including his brother, he was followed closely without any therapies because he had never had an episode of syncope. He was implanted with an S-ICD without any trouble. Seven months later, frequent S-ICD shocks for VF storms occurred. His VF was controlled by using intravenous amiodarone, which was converted to an oral preparation. However, his VF recurred after another 2 months. The analysis of his S-ICD data revealed that 4 consecutive shock deliveries could not terminate his VF and the final shock delivered could fortunately terminate it because of a high defibrillation threshold test (DFT) due to an increasing shock impedance (64 to 90 Ω). First, we performed an epicardial Brugada syndrome ablation and subsequently replaced and repositioned the S-ICD lead from a left to a right parasternal site. After the re-implantation of the S-ICD, the DFT test improved to within normal range. According to the pathological analysis, infiltration of inflammatory cells and extensive fibrosis were confirmed in the subcutaneous tissue around the shock lead and S-ICD body. CONCLUSION: Frequent S-ICD shocks for VF storms might cause various pathological changes around the device and lead to a high DFT. BioMed Central 2020-03-13 /pmc/articles/PMC7071569/ /pubmed/32169057 http://dx.doi.org/10.1186/s12872-020-01405-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Nakao, Yasuhisa
Suenari, Kazuyoshi
Yamashiro, Kohei
Nakagawa, Hiroshi
Shiode, Nobuo
Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title_full Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title_fullStr Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title_full_unstemmed Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title_short Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
title_sort refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a brugada syndrome case
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071569/
https://www.ncbi.nlm.nih.gov/pubmed/32169057
http://dx.doi.org/10.1186/s12872-020-01405-4
work_keys_str_mv AT nakaoyasuhisa refractorinesstosubcutaneousimplantablecardioverterdefibrillatorafterfrequenttherapiesforventricularfibrillationstormsinabrugadasyndromecase
AT suenarikazuyoshi refractorinesstosubcutaneousimplantablecardioverterdefibrillatorafterfrequenttherapiesforventricularfibrillationstormsinabrugadasyndromecase
AT yamashirokohei refractorinesstosubcutaneousimplantablecardioverterdefibrillatorafterfrequenttherapiesforventricularfibrillationstormsinabrugadasyndromecase
AT nakagawahiroshi refractorinesstosubcutaneousimplantablecardioverterdefibrillatorafterfrequenttherapiesforventricularfibrillationstormsinabrugadasyndromecase
AT shiodenobuo refractorinesstosubcutaneousimplantablecardioverterdefibrillatorafterfrequenttherapiesforventricularfibrillationstormsinabrugadasyndromecase